Mannkind (MNKD) Receivables (2014 - 2026)
Mannkind (MNKD) posted quarterly Receivables of $28.1 million for Q1 2026, down 2.64% year-over-year from $28.9 million in Q1 2025, and down 26.66% quarter-over-quarter from $38.4 million in Q4 2025.
Mannkind (MNKD) Receivables (2014 - 2026) Analysis & Trends
Mannkind (MNKD) has reported Receivables for 13 consecutive years, with $28.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables fell 2.64% year-over-year to $28.1 million; the TTM figure through Mar 2026 stood at $28.1 million (down 2.64% YoY), while the FY2025 annual figure was $38.4 million, up 225.03% from the prior year.
- Receivables slipped to $28.1 million in Q1 2026 per MNKD's latest filing, from $38.4 million in the prior quarter.
- Across five years, Receivables topped out at $38.4 million in Q4 2025 and bottomed at $900000.0 in Q1 2023.
- Historically, Receivables has averaged $20.3 million across 5 years, with a median of $19.9 million in 2024.
- Annual changes were most pronounced in 2023 — Receivables plunged 91.28% — and 2024, when it jumped 2112.44%.
- Mannkind's Receivables stood at $16.8 million in 2022, then retreated by 11.31% to $14.9 million in 2023, then slipped by 20.78% to $11.8 million in 2024, then jumped by 225.03% to $38.4 million in 2025, then decreased by 26.66% to $28.1 million in 2026.
- Business Quant data shows MNKD's Receivables at $28.1 million in Q1 2026, $38.4 million in Q4 2025, and $17.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.93 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.06 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1.84 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 912.74 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 215.33 Mn |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn | 43.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.21 Mn |
| Mar 31, 2026 | 28.14 Mn |
| Dec 31, 2025 | 38.37 Mn |
| Sep 30, 2025 | 17.38 Mn |
| Jun 30, 2025 | 27.14 Mn |
| Mar 31, 2025 | 28.90 Mn |
| Dec 31, 2024 | 11.80 Mn |
| Sep 30, 2024 | 18.18 Mn |
| Jun 30, 2024 | 23.35 Mn |
| Mar 31, 2024 | 19.91 Mn |
| Dec 31, 2023 | 14.90 Mn |
| Sep 30, 2023 | 22.22 Mn |
| Jun 30, 2023 | 27.99 Mn |
| Mar 31, 2023 | 900,000.00 |
| Dec 31, 2022 | 16.80 Mn |
| Sep 30, 2022 | 24.09 Mn |
| Jun 30, 2022 | 15.43 Mn |
| Mar 31, 2022 | 10.32 Mn |
| Dec 31, 2021 | 5.04 Mn |
| Sep 30, 2021 | 9.45 Mn |